Citation Impact
Citing Papers
Global increase and geographic convergence in antibiotic consumption between 2000 and 2015
2018 Standout
A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis
2021 StandoutScienceNobel
Short-Lived Plasmablasts Dominate the Early Spontaneous Rheumatoid Factor Response: Differentiation Pathways, Hypermutating Cell Types, and Affinity Maturation Outside the Germinal Center
2005
AID−/−μs−/− Mice Are Agammaglobulinemic and Fail to Maintain B220−CD138+ Plasma Cells
2007 StandoutNobel
Heparin-Protein Interactions
2002 Standout
Therapeutic Effects of Antibodies Against Adhesion Molecules in Murine Collagen Type II-Induced Arthritis
1995
Immunological Memory Stabilizing Autoreactivity
2006
Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases
2004
Vancomycin‐Resistant and Vancomycin‐Susceptible Enterococcal Bacteremia: Comparison of Clinical Features and Outcomes
1998
Increase of B cell-activating factor of the TNF family (BAFF) after rituximab treatment: insights into a new regulating system of BAFF production
2006
Reconstitution of peripheral blood B cells after depletion with rituximab in patients with rheumatoid arthritis
2006
Monocyte and macrophage heterogeneity
2005 Standout
Chronic Venous Disease
2006 Standout
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
Memory B and memory plasma cells
2010
Interleukin-10-Producing Plasmablasts Exert Regulatory Function in Autoimmune Inflammation
2014 StandoutNobel
Should Rituximab be Considered as the First-Choice Treatment for Severe Autoimmune Rheumatic Diseases?
2007
How the Blood Talks to the Brain Parenchyma and the Paraventricular Nucleus of the Hypothalamus During Systemic Inflammatory and Infectious Stimuli
2000
Clinical Effects and Safety of Rituximab for Treatment of Refractory Pediatric Autoimmune Diseases
2007
Variability in the biological response to anti-CD20 B cell depletion in systemic lupus erythaematosus
2008
The Effect of Vancomycin and Third-Generation Cephalosporins on Prevalence of Vancomycin-Resistant Enterococci in 126 U.S. Adult Intensive Care Units
2001
How circulating cytokines trigger the neural circuits that control the hypothalamic–pituitary–adrenal axis
2001
Gamma/Delta Cells
1993 Nobel
The site of primary T cell activation is a determinant of the balance between intrahepatic tolerance and immunity
2004
Titrating Rituximab to Circulating B Cells to Optimize Lymphocytolytic Therapy in Idiopathic Membranous Nephropathy
2007
Microvascular changes in chronic venous insufficiency—a review
1995
B cell depletion therapy in systemic lupus erythaematosus: relationships among serum B lymphocyte stimulator levels, autoantibody profile and clinical response
2007
Ectopic Lymphoid Structures Support Ongoing Production of Class-Switched Autoantibodies in Rheumatoid Synovium
2009
Rituximab is effective in the treatment of refractory ophthalmic Wegener's granulomatosis
2009
B-cell depletion with rituximab in the treatment of autoimmune diseases
2007
The Pathogenesis of Rheumatoid Arthritis
2011 Standout
Efficacy of Anti‐CD20 Treatment in Patients with Rheumatoid Arthritis Resistant to a Combination of Methotrexate/Anti‐TNF Therapy
2007
Anti‐CD20 therapy in patients with rheumatoid arthritis: Predictors of response and B cell subset regeneration after repeated treatment
2008
Synovial tissue response to rituximab: mechanism of action and identification of biomarkers of response
2007
B-cell inhibitors as therapy for rheumatoid arthritis: An update
2007
B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis
2008 Standout
A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness
2006
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
THE FUNCTION OF γδ T CELLS
1992 StandoutNobel
B-cell targeting in rheumatoid arthritis and other autoimmune diseases
2006
The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: Results of a phase IIB randomized, double‐blind, placebo‐controlled, dose‐ranging trial
2006
Characterization of Liver T–Cell Receptor γδ+ T Cells Obtained From Individuals Chronically Infected With Hepatitis C Virus (Hcv): Evidence for These T Cells Playing A Role in the Liver Pathology Associated With Hcv Infections
2001 StandoutNobel
Identification of the Sulfated Monosaccharides of GlyCAM-1, an Endothelial-Derived Ligand for L-Selectin
1994 StandoutNobel
Graves' Ophthalmopathy
2010 Standout
Drug repurposing: progress, challenges and recommendations
2018 Standout
CCR7 Coordinates the Primary Immune Response by Establishing Functional Microenvironments in Secondary Lymphoid Organs
1999 Standout
Gender-Dependent Differences in Outcome After the Treatment of Infection in Hospitalized Patients
1999
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression
1998 StandoutNature
Two subsets of memory T lymphocytes with distinct homing potentials and effector functions
1999 StandoutNature
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care
2001 Standout
Type 1 diabetes
2013 Standout
Markers for the lymphatic endothelium: In search of the holy grail?
2001
L-selectin and its biological ligands
1993
B cell therapy for rheumatoid arthritis: the rituximab (anti-CD20) experience
2003
Activation-Induced Cytidine Deaminase Expression in CD4+ T Cells is Associated with a Unique IL-10-Producing Subset that Increases with Age
2011 StandoutNobel
B cells in rheumatoid arthritis: from hypothesis to the clinic
2005
Leprosy
2004 Standout
Rheumatoid arthritis
2010 Standout
Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjögren's syndrome
2006
Vancomycin-Resistant Enterococcal Infections
2000 Standout
Duration of Humoral Immunity to Common Viral and Vaccine Antigens
2007
Anti-CD20 (rituximab) treatment improves atopic eczema
2008
Assessment of rituximab's immunomodulatory synovial effects (ARISE trial). 1: clinical and synovial biomarker results
2007
Anti-CCP antibodies: the past, the present and the future
2011
B cells as therapeutic targets in autoimmune neurological disorders
2008
Lack of efficacy of rituximab in Wegener's granulomatosis with refractory granulomatous manifestations
2005
Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis
2010 Standout
Nine patients with anti‐neutrophil cytoplasmic antibody‐positive vasculitis successfully treated with rituximab
2005
CD62L Is Required on Effector Cells for Local Interactions in the CNS to Cause Myelin Damage in Experimental Allergic Encephalomyelitis
2001
Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm
1994 Standout
Spleen tyrosine kinase: a novel target for therapeutic intervention of rheumatoid arthritis
2008
The prognostic landscape of genes and infiltrating immune cells across human cancers
2015 Standout
Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression
2008
Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
2021 Standout
Development of psoriasis after B cell depletion with rituximab
2007
Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function
2009
B lineage cells in the inflammatory central nervous system environment: Migration, maintenance, local antibody production, and therapeutic modulation
2006
Long-Term Control of HIV by CCR5 Delta32/Delta32 Stem-Cell Transplantation
2009 Standout
Rituximab for Refractory Wegener's Granulomatosis
2005
Inhibition of delayed-type contact hypersensitivity in mice deficient in both E-selectin and P-selectin
1996
Leukocytes: Their role in the etiopathogenesis of skin damage in venous disease
1993
Flying Under the Radar: The Immunobiology of Hepatitis C
2006 StandoutNobel
Requirement for CD44 in Activated T Cell Extravasation into an Inflammatory Site
1997 StandoutScience
Estimating the global incidence of traumatic brain injury
2018 Standout
Broadly Neutralizing Immune Responses against Hepatitis C Virus Induced by Vectored Measles Viruses and a Recombinant Envelope Protein Booster
2012 StandoutNobel
Part 2: Synopsis of B-lymphocyte targeted therapy of ANCA-associated vasculitis.
2007
Lymphatic Metastasis in the Absence of Functional Intratumor Lymphatics
2002 StandoutScience
Preferential Localization of Effector Memory Cells in Nonlymphoid Tissue
2001 StandoutScience
Lack of a role for transforming growth factor-β in cytotoxic T lymphocyte antigen-4-mediated inhibition of T cell activation
2001 StandoutNobel
Etanercept in treatment of Felty's syndrome
2005
Tumour necrosis factor-alpha (TNF-α) synthesis is associated with the skin and peripheral nerve pathology of leprosy reversal reactions
1995
The site of primary T cell activation is a determinant of the balance between intrahepatic tolerance and immunity
2004
Migration and Differentiation of Autoreactive B-1 Cells Induced by Activated γ/δ T Cells in Antierythrocyte Immunoglobulin Transgenic Mice
2000 StandoutNobel
Role of hsp60 during Autoimmune and Bacterial Inflammation
1991
Dual inhibition of VLA-4 and LFA-1 maximally inhibits cutaneous delayed-type hypersensitivity-induced inflammation.
1993
B-Cell Depletion for Autoimmune Thrombocytopenia and Autoimmune Hemolytic Anemia in Pediatric Systemic Lupus Erythematosus
2008
T CELL MEMORY
1998
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
2005 Standout
Detection of T cell responses to a ubiquitous cellular protein in autoimmune disease
2014 StandoutScienceNobel
Investigation of Chronic Venous Insufficiency
2000 Standout
L-selectin-deficient mice have impaired leukocyte recruitment into inflammatory sites.
1995
Calcium-Dependent Heparin-Like Ligands For L-Selectin in Nonlymphoid Endothelial Cells
1993 Science
Selective response of gamma delta T-cell hybridomas to orthomyxovirus-infected cells
1996 StandoutNobel
The STRING database in 2021: customizable protein–protein networks, and functional characterization of user-uploaded gene/measurement sets
2020 Standout
Thymus and Autoimmunity: Production of CD25+CD4+ Naturally Anergic and Suppressive T Cells as a Key Function of the Thymus in Maintaining Immunologic Self-Tolerance
1999 StandoutNobel
Free Radicals in the Physiological Control of Cell Function
2002 Standout
Repeated B lymphocyte depletion with rituximab in rheumatoid arthritis over 7 yrs
2006
CD34-deficient mice have reduced eosinophil accumulation after allergen exposure and show a novel crossreactive 90-kD protein
1996 StandoutNobel
Differential Roles of Cytokine Receptors in the Development of Epidermal γδ T Cells
2001 StandoutNobel
B-Lymphocyte Depletion With Rituximab and β-Cell Function: Two-Year Results
2013
Characterization of Hepatitis C Virus Core-Specific Immune Responses Primed in Rhesus Macaques by a Nonclassical ISCOM Vaccine
2001 StandoutNobel
Works of Jonathan Edwards being referenced
The monoclonal antibody MEL‐14 can block lymphocyte migration into a site ofchronic inflammation
1992
Prospects for B-cell-targeted therapy in autoimmune disease
2004
Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis
2003
Tγδ Cells and their Subsets in Blood and Synovial Tissue from Rheumatoid Arthritis Patients
1990
Risk Factors for Mortality Associated With Enterococcal Bloodstream Infections
1996
Remission of inflammatory arthropathy in association with anti-CD20 therapy for non-Hodgkin's lymphoma
1999
Binding of antibodies raised against tumour necrosis factor alpha (TNF?) to blood vessels and macrophages in inflamed synovial tissue
1991
Incidence of sport-related traumatic brain injury and risk factors of severity: a population-based epidemiologic study
2013
Circulating levels of B lymphocyte stimulator in patients with rheumatoid arthritis following rituximab treatment: Relationships with B cell depletion, circulating antibodies, and clinical relapse
2006
Risk Factors for Mortality Associated with Enterococcal Bloodstream Infections
1996
Leukocytes: Their role in the etiopathogenesis of skin damage in venous disease
1993